CTIS2022-502455-57-01进行中（未招募）1 期
Glucagon enhanced insulin absorption in Diabetes Mellitus type 1
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •1. DM1 for at least 1 year., 2.Age 18 – 70 years, 3.Last known HbA1c <86 mmol/mol (< 10.0%), 4.Treated with continuous SC insulin infusion (CSII) by an insulin pump or with multiple daily insulin injections (MDII).
排除标准
- •1.Pregnant women or women trying to conceive (women will not be screened by a pregnancy test)., 2.Any chronic disease, including psychiatric illnesses, judged incompatible with participation in the study., 3.Unfit for participation for any reason as judged by the investigators, 4. Known hypersensitivity to glucagon or any of the excipients of the drug formulation, 5. Known phaeochromocytoma
研究者
相似试验
终止
2 期
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1Type 1 DiabetesNCT05960565St. Olavs Hospital9
已完成
不适用
Glucagon challenge in patients with type 2 diabetes mellitus10018424DiabetesNL-OMON33022Centre for Human Drug Research16
Unknown
不适用
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00655603University Hospital, Gentofte, Copenhagen20
进行中（未招募）
2 期
Effects of GRA in Patients With Type 1Type 1 DiabetesNCT04779645University of California, San Diego30
Unknown
3 期
Glucagon Modulation of Ghrelin SecretionHealthy SubjectsObesityDiabetes Mellitus, Type 1NCT00929812Charite University, Berlin, Germany38